CTRI/2012/01/002325已完成未知
A single-center, randomized, controlled study to evaluate the safety and effectiveness of the electro muscular stimulation device to improve skin elasticity, firmness and to reduce the signs of facial aging in healthy adults after 10 weeks of product use - EMS Study
Vercel Inc0 个研究点目标入组 70 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.35 - 50 years of age.( 40% male and 60% female )
- •2.Visual signs of aging on the face with mild/moderate to severe wrinkles.
- •3.In general good health,
- •Free of dermatological conditions such as eczema, seborrheic dermatitis and psoriasis.
- •4.Signing of an Informed Consent Contract in conformance with CFR Part 50: Protection of Human Subjects.
- •5.Dependability and intelligence in following directions.
- •6.Completion of a Panelist Profile/Medical History.
- •7.Subjects must be willing to maintain their normal diet throughout the duration of the study.
- •8.Using acceptable methods of birth control.
排除标准
- •1.Pregnant women (or pregnancy within last 3 months).
- •2.Inadequate precaution or procedure to prevent pregnancy (women of child- bearing potential only).
- •3.Treatment for any type of cancer within the last six months.
- •4.Use of any prescribed anti-inflammatory drug, immunosuppressive drugs or antihistamine medication (steroid nose drops and/or eye drops are permitted). Any over-the-counter pain medication that is ingested in quantities exceeding label instructions.
- •5.Damaged skin in or around test sites which include sunburn, extremely deep tans, uneven skin tones, tattoos, scars, excessive hair, numerous freckles or other disfiguration of the test site.
- •6.Individuals who have any implanted medical devices (pacemaker, pump, catheter, etc.).
- •7.Current or history of a medical condition that would contraindicate treatment with the product, such as epilepsy, hernia, abdominal ulcer, diabetes, or other conditions which, in the opinion of the Investigator, would place the participant at risk.
- •8.A current skin disease of any type at the test site (e.g. acne, eczema, psoriasis, burns, abrasions, etc.)
- •9.Heavy alcohol consumption in the opinion of the investigator.
- •10.A fever in the last 12 hours prior to the first application of the test device.
- •11.History of heart disease.
- •12.History of stroke.
- •13.History of malignant disease.
- •14.Insulin dependent diabetes.
- •15.Concurrent medication likely to affect the response to the test article or confuse the results of the study (e.g. routine high dose use of any drugs that may artificially affect skin tone).
- •16.Individuals who are currently participating in any other clinical. Investigation, or who have participated in a study with the same indication within 1 year.
- •17.Principal investigator for this study, or member of study staff.
- •18.Participants with skin conditions such as obvious sun damage, increased pigmentation and / or telangectasia.
- •19.Any dental inflammation or other acute dental condition.
- •20.Individuals who have had facial surgery.
- •21.Patients with facial muscle fever.
研究者
相似试验
进行中（未招募）
1 期
Single-center, randomized, controlled study to evaluate the effects of a six-month treatment with renal glucose transport inhibitor (SGLT2i) drugs on markers of senescence, inflammation and tubulointerstitial damage in the kidney of patients with chronic kidney disease with or without type 2 diabetesChronic Kidney DeseasMedDRA version: 21.1Level: LLTClassification code 10050441Term: Chronic renal insufficiencySystem Organ Class: 100000004857EUCTR2020-004835-26-ITIRCCS-A.O.U. SAN MARTINO-IST38
已完成
不适用
A randomised, single centre, controlled study to assess whether listening to self selected recorded music reduces the anxiety of patients undergoing their first radiotherapy treatment.anyone diagnosed with cancer needing radiotherapy - radical intent for treatmentanxiety during initial radiotherapyCancer - Other cancer typesACTRN12609000589280Peter MacCallum Cancer Centre100
进行中（未招募）
不适用
A single center, randomized, controlled study to determine the irritant potential of topical acne formulations on intact healthy skin on the back following repeated application during a 21-day treatment period - Cumulative irritiation testEUCTR2009-014550-14-DEDow Pharmaceutical Sciences, Inc on behalf of Coria Laboratories33
招募中
不适用
A prospective, single-center, randomized study to evaluate the effect of sarpogrelate, a selective serotonin receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients with variant anginaDiseases of the circulatory systemKCT0000623Samsung Medical Center200
招募中
不适用
Verification of the effect of a Trunk Solution Improves Posture for patients with Parkinson's Disease of Forward Bending Posture.s DiseaseParkinson's DiseaseJPRN-UMIN000049433agasaki Kita Hospital40